medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-12-26-32medsovet-2006Research ArticleАРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯARTERIAL HYPERTENSIONЛЕЧЕНИЕ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ И ПРОФИЛАКТИКА СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У ЖЕНЩИНЫ РЕПРОДУКТИВНОГО ВОЗРАСТА С МИГРЕНЬЮTHERAPY OF ARTERIAL HYPERTENSION AND PREVENTION OF CARDIOVASCULAR DISEASES IN WOMAN OF REPRODUCTIVE AGE SUFFERING FROM MIGRAINE. CLINICAL REVIEWКислякО. А.KislyakO. A.

д.м.н., профессор

MD, Prof.

СтародубоваА. В.StarodubovaA. V.

д.м.н., профессор

MD, Prof.

ЧервяковаЮ. Б.ChervyakovaY. B.

к.м.н.

PhD in medicine

Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава РоссииРоссияPirogov Russian National Research Medical University of the Ministry of Health of RussiaRussian FederationРоссийский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава России; Федеральный исследовательский центр питания, биотехнологии и безопасности пищиРоссияPirogov Russian National Research Medical University of the Ministry of Health of Russia; Federal Research Center of Nutrition, Biotechnology and Food SafetyRussian Federation2017021120170122632Copyright © Кисляк О.А., Стародубова А.В., Червякова Ю.Б., 20172017Кисляк О.А., Стародубова А.В., Червякова Ю.Б.Kislyak O.A., Starodubova A.V., Chervyakova Y.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2006

Разбирается клинический случай артериальной гипертензии в сочетании с мигренью у женщины репродуктивного возраста. Обсуждается тактика антигипертензивной терапии с позиций лечения артериальной гипертензии и профилактики сердечно-сосудистых заболеваний и предотвращения приступов мигрени. Проводится анализ существующих рекомендаций по профилактике кардиоваскулярных и цереброваскулярных заболеваний у женщин и предлагается алгоритм медикаментозной терапии, основанный на имеющихся данных об общности патофизиологических механизмов развития артериальной гипертензии и мигрени и результатах клинических исследований.

 

 

 

 

A clinical case of the arterial hypertension in combination with migraine is considered in a woman of a reproductive age. The tactics of the antihypertensive therapy is discussed from the point of view of therapy of arterial hypertension and prevention of cardiovascular diseases and prevention of migraine attacks. Existing recommendations on prevention of cardiovascular and cerebrovascular diseases in women are analyzed and an algorithm of the drug therapy based on the available data about the general nature of pathophysiological mechanism of development of arterial hypertension and migraine is provided.

артериальная гипертензиямигреньмолодой возрастсердечно-сосудистые заболеванияблокаторы рецепторов ангиотензинакандесартанarterial hypertensionmigraineyoung agecardiovascular diseaseangiotensin blocking receptorsCandesartanReferencesCardiovascular disease in Europe: epidemiological update 2016. European Heart Journal, 2016, 0: 1–14. doi:10.1093/eurheartj/ehw334.Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal, 2016, 0: 1–14. doi:10.1093/eurheartj/ehw334.Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the Аmerican Heart Association. Circulation, 2011, 123: 1243–62.Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the Аmerican Heart Association. Circulation, 2011, 123: 1243–62.Towfighi, A, Zheng, L, Ovbiagele, B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med, 200, 169: 1762-1766.Towfighi, A, Zheng, L, Ovbiagele, B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med, 200, 169: 1762-1766.George J, Rapsomaniki E, Pujades-Rodriguez M, Shah AD, Denaxas S, Herrett E, Smeeth L, Timmis A, Hemingway H. How Does Cardiovascular Disease First Present in Women and Men? Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People. Circulation, 2015, 132: 1320-1328. DOI: 10.1161/CIRCULATIONAHA.114.013797.George J, Rapsomaniki E, Pujades-Rodriguez M, Shah AD, Denaxas S, Herrett E, Smeeth L, Timmis A, Hemingway H. How Does Cardiovascular Disease First Present in Women and Men? Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People. Circulation, 2015, 132: 1320-1328. DOI: 10.1161/CIRCULATIONAHA.114.013797.Guidelines for the Prevention of Stroke in Women A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2014, 45: 1545-1588. DOI: 10.1161/01. str.0000442009.06663.48.Guidelines for the Prevention of Stroke in Women A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2014, 45: 1545-1588. DOI: 10.1161/01. str.0000442009.06663.48.O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S, INTERSTROKE Investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet, 2010, 376: 112–123.O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S, INTERSTROKE Investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet, 2010, 376: 112–123.National Center for Health Statistics. Health, United States, 2011. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2012. http: //www.cdc.gov/nchs/hus/contents2011. htm#031. Accessed December 31, 2012.National Center for Health Statistics. Health, United States, 2011. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2012. http: //www.cdc.gov/nchs/hus/contents2011. htm#031. Accessed December 31, 2012.Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: estimates from the Framingham Study. Stroke, 2006, 37: 345–350.Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: estimates from the Framingham Study. Stroke, 2006, 37: 345–350.Подзолков В.И., Брагина А.Е. Комбинированная терапия артериальной гипертензии: фокус на лечение женщин. Лечебное дело, 2013, 2: 31-38.Подзолков В.И., Брагина А.Е. Комбинированная терапия артериальной гипертензии: фокус на лечение женщин. Лечебное дело, 2013, 2: 31-38.Табеева Г.Р., Муранова А.В., Кострыгина Е.Н., Сергеев А.В. Мигрень и артериальная гшпертензия. Неврология, нейропсихиатрия, психосоматика, 2015, 7(4): 4–10.Табеева Г.Р., Муранова А.В., Кострыгина Е.Н., Сергеев А.В. Мигрень и артериальная гшпертензия. Неврология, нейропсихиатрия, психосоматика, 2015, 7(4): 4–10.Kurth T, Diener HC. Current views of the risk of stroke for migraine with and migraine without aura. Curr Pain Headache Rep, 2006, 10(3): 214-20.Kurth T, Diener HC. Current views of the risk of stroke for migraine with and migraine without aura. Curr Pain Headache Rep, 2006, 10(3): 214-20.12. Boubacar S, Assadeck H, Diallo IM, Cisse O, Ntenga P, Adji DB, Diagne NS, Maiga DD, Adehossi EO, Maiga Y, Toure K, Ndiaye M, Diop AG, Ndiaye MM. Migraine in women: what specificities? A review. J Womens Health Care, 2017, 6: 1, doi: 10: 4172/2167-0420.1000349.12. Boubacar S, Assadeck H, Diallo IM, Cisse O, Ntenga P, Adji DB, Diagne NS, Maiga DD, Adehossi EO, Maiga Y, Toure K, Ndiaye M, Diop AG, Ndiaye MM. Migraine in women: what specificities? A review. J Womens Health Care, 2017, 6: 1, doi: 10: 4172/2167-0420.1000349.2013 ESH/ESC Guidelines for the management of arterial hypertension. TheTask Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 2013, 31: 1281–1357.2013 ESH/ESC Guidelines for the management of arterial hypertension. TheTask Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 2013, 31: 1281–1357.Российское медицинское общество по артериальной гипертонии (РМОАГ), Всероссийское научное общество кардиологов (ВНОК). Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр). Системные гипертензии, 2010, 3: 5–26.Российское медицинское общество по артериальной гипертонии (РМОАГ), Всероссийское научное общество кардиологов (ВНОК). Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр). Системные гипертензии, 2010, 3: 5–26.Keto J, Ventola H, Jokelainen J, Linden К, Keinänen-Kiukaanniemi S, Timonen М Ylisaukko-oja Т, Auvinen J. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart, 2016, 3: e000358. doi: 10.1136/openhrt-2015-000358.Keto J, Ventola H, Jokelainen J, Linden К, Keinänen-Kiukaanniemi S, Timonen М Ylisaukko-oja Т, Auvinen J. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart, 2016, 3: e000358. doi: 10.1136/openhrt-2015-000358.The International Classification of Headache Disorders, 3rd edition (beta version). Headache Classification Committee of the International Headache Society (IHS). Cephalalgia, 2013, 33(9): 629–808. International Headache Society 2013 Reprints and permissions: sage-pub.co.uk/journals Permissions.nav DOI: 10.1177/0333102413485658.The International Classification of Headache Disorders, 3rd edition (beta version). Headache Classification Committee of the International Headache Society (IHS). Cephalalgia, 2013, 33(9): 629–808. International Headache Society 2013 Reprints and permissions: sage-pub.co.uk/journals Permissions.nav DOI: 10.1177/0333102413485658.Hamed SA. Blood pressure changes in pftients with migraine: evidences, controversial views and potential mechanisms of comorbidity. J Neurology and Neuroscience, 2010, 2: 2. doi10: 3823/306.Hamed SA. Blood pressure changes in pftients with migraine: evidences, controversial views and potential mechanisms of comorbidity. J Neurology and Neuroscience, 2010, 2: 2. doi10: 3823/306.Стародубова А.В., Драенкова О.В., Кисляк О.А., Копелев А.М., Косюра С.Д., Хаутиева Ф.М., Сергиенко В.И., Говорун В.М., Джеджея Л.В. Особенности жирового обмена у молодых женщин с избыточным и нормальным приростом массы тела во время беременности. Вестник Российского государственного медицинского университета, 2009, 2: 10-15.Стародубова А.В., Драенкова О.В., Кисляк О.А., Копелев А.М., Косюра С.Д., Хаутиева Ф.М., Сергиенко В.И., Говорун В.М., Джеджея Л.В. Особенности жирового обмена у молодых женщин с избыточным и нормальным приростом массы тела во время беременности. Вестник Российского государственного медицинского университета, 2009, 2: 10-15.Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M. European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis, 2012. 122 р.Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M. European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis, 2012. 122 р.Sachdec A, Marmura MJ. Metabolic syndrome and migraine. Frontiers in Neurology, 2012, 3: 8. Doi: 10/3389/fntur.2012.00161.Sachdec A, Marmura MJ. Metabolic syndrome and migraine. Frontiers in Neurology, 2012, 3: 8. Doi: 10/3389/fntur.2012.00161.2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016 Aug 27. pii: ehw272. [Epub ahead of print]. Eur Heart J, 2016, 37(39): 2999-3058.2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016 Aug 27. pii: ehw272. [Epub ahead of print]. Eur Heart J, 2016, 37(39): 2999-3058.Cushman WC, Goff DC. More HOPE for prevention with ststins. New Engl J Med, 2016, DOI: 10.1056/NEJMe1603504. Copyright © 2016 Massachusetts Medical Society.Cushman WC, Goff DC. More HOPE for prevention with ststins. New Engl J Med, 2016, DOI: 10.1056/NEJMe1603504. Copyright © 2016 Massachusetts Medical Society.Bundy J D, Li С, Stuchlik P, Bu X, Kelly TN, Mills KT, He H, Chen J, Whelton PK, He J. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality A Systematic Review and Network Meta-analysis. JAMA Cardiol. doi: 10.1001/jamacardio.2017.1421 Published online May 31, 2017.Bundy J D, Li С, Stuchlik P, Bu X, Kelly TN, Mills KT, He H, Chen J, Whelton PK, He J. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality A Systematic Review and Network Meta-analysis. JAMA Cardiol. doi: 10.1001/jamacardio.2017.1421 Published online May 31, 2017.Zheng Z, Shi H, Jia J, Li D, Lin S. A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension. Journal of the Renin-Angiotensin-Aldosterone System, 2011, Published online March 18, 1470320310391503.Zheng Z, Shi H, Jia J, Li D, Lin S. A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension. Journal of the Renin-Angiotensin-Aldosterone System, 2011, Published online March 18, 1470320310391503.Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA, 2003, 289(1): 65-69.Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA, 2003, 289(1): 65-69.Soliman S, Ishrat T, Pillai A, Somanath P R, Ergul A, El-Remessy AB, Fagan SC. Candesartan Induces a Prolonged Proangiogenic Effect and Augments Endothelium-Mediated Neuroprotection after Oxygen and Glucose Deprivation: Role of Vascular Endothelial Growth Factors A and B. J Pharmacol Exp Ther, 349: 444–457.Soliman S, Ishrat T, Pillai A, Somanath P R, Ergul A, El-Remessy AB, Fagan SC. Candesartan Induces a Prolonged Proangiogenic Effect and Augments Endothelium-Mediated Neuroprotection after Oxygen and Glucose Deprivation: Role of Vascular Endothelial Growth Factors A and B. J Pharmacol Exp Ther, 349: 444–457.The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines. Headache, 2012, 52: 930-945.The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines. Headache, 2012, 52: 930-945.

The authors declare that there are no conflicts of interest present.